Under this agreement, BekaertDeslee will have exclusive worldwide rights to apply HeiQ Allergen* Tech to mattress ticking, which is used to cover mattresses. HeiQ Allergen* Tech, which was launched in October 2022, is a 100% biobased, naturally derived technology that reduces exposure to inanimate allergens such as house dust mite matter, and pet allergens with the help of active probiotics.
It has been granted the Allergy UK Seal of Approval by The British Allergy Foundation following a review and assessment of the technology. Additionally, an independent certification has shown that HeiQ Allergen* Tech successfully reduces 83,6% of cat (hair) allergen, 76,5% of dog (hair) allergen, and 96,6% of house dust mite matter allergen.
HeiQ Group Co-Founder and CEO, Carlo Centonze said:
“We are delighted to secure this contract with a world-class partner just weeks after launching HeiQ Allergen* Tech, once again demonstrating our ability to develop and rapidly commercialize new technology for which there is strong global demand. Mattresses represent just one of many fields in the multi-billion home textiles market where HeiQ Allergen* Tech can be applied, and we are building our pipeline of opportunities in areas such as carpet, furniture, and bed linens. Hygiene remains a core function for HeiQ and this latest product helps to solidify our position as a leading provider of nature-based hygiene solutions. With more than 90% of bedrooms in the US having three or more detectable allergens, this partnership with BekaertDeslee enables us to improve the lives of people significantly, which is central to our purpose.”
Frédéric Beucher, CEO of BekaertDeslee, said:
“Being the world’s leading specialist in the development and manufacturing of mattress textiles gives BekaertDeslee a special responsibility when it comes to providing the market with innovative solutions that address real-world problems. This new technology will contribute to our efforts in introducing sustainable products that provide better conditions for a good night’s sleep. We will commercialize this exclusive technology under our well-known Purotex brand, by naming the new generation of our products Purotex+ powered by HeiQ Allergen* Tech.”
* Inanimate allergens such as house dust mite matter & pet allergens.
Founded in 2005 as a spin-off from the Swiss Federal Institute of Technology Zurich (ETH) and listed on the London Stock Exchange Main Market (XLON:HEIQ), HeiQ is a leader in textile and materials innovation creating some of the most effective, durable and high-performance technologies on the market today. HeiQ strives to improve the lives of billions of people through pioneering textiles and materials innovation. Combining three areas of expertise – scientific research, specialty materials manufacturing, and consumer ingredient branding – HeiQ is the ideal innovation partner to create differentiating and sustainable products and capture the added value at the point of sale. With its 14 offices, 7 manufacturing sites, and 7 R&D hubs, HeiQ today employs 240 professionals. It has a total capacity of 45’000 tons of specialty chemicals per year and serves over 1’000 industrial customers in over 60 countries. Today, HeiQ’s consumer goods and medical devices can be found in 56 countries. For more information, visit www.heiq.com
HeiQ Materials AG
Ruetistrasse 12
CH8952 Schlieren
Telefon: +41 (56) 2506850
Telefax: +41 (56) 2506841
http://www.heiq.com
PR & Corporate Communications Director
E-Mail: jorge.fiens@heiq.com
